Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic fatty liver disease

Medicine (United States)

Volumn 94, Issue 9, 2015, Pages e573-

  Chung, Goh Eun ^a   Kim, Donghee ^a   Kwark, Min Sun ^a   Kim, Won ^b   Yim, Jeong Y ^a   Kim, Yoon J ^c   Yoon, Jung H ^c  

^a Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHRONIC LIVER DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; HYPERTRANSAMINASEMIA; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NONALCOHOLIC FATTY LIVER; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE; BLOOD; COMORBIDITY; HEALTH BEHAVIOR; LIVER; MIDDLE AGED; MORPHOMETRICS; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; SOUTH KOREA;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHTS AND MEASURES; COHORT STUDIES; COMORBIDITY; FEMALE; HEALTH BEHAVIOR; HUMANS; INTRA-ABDOMINAL FAT; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; REPUBLIC OF KOREA; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84926343899     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000573     Document Type: Article

References (35)

1. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342:1266-1271
2. Burns CJ, Boswell JM, Olsen GW. Liver enzyme activity and body mass index. J Occup Environ Med. 1996;38:1248-1252
3. Sull JW, Yun JE, Lee SY, et al. Body mass index and serum aminotransferase levels in Korean men and women. J Clin Gastroenterol. 2009;43:869-875
4. Kim J, Jo I. Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults. Eur J Clin Nutr. 2010;64:169-175
5. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003;124:71-79
6. Stranges S, Dorn JM, Muti P, et al. Body fat distribution, relative weight, and liver enzyme levels: A population-based study. Hepatology. 2004;39:754-763
7. Ruhl CE, Everhart JE. Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology. 2010;138:1346-1356
8. Song HR, Yun KE, Park HS. Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women. Am J Clin Nutr. 2008;88:16-21
9. Mochizuki K, Miyauchi R, Misaki Y, et al. Accumulation of visceral fat is positively associated with serum ALT and gamma-GTP activities in healthy and preclinical middle-aged Japanese men. J Nutr Sci Vitaminol (Tokyo). 2011;57:65-73
10. Vernon G, Baranova A, Younossi ZM. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274-285
11. The Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2013;19:325-348
12. Jakobsen MU, Berentzen T, Sorensen TI, et al. Abdominal obesity and fatty liver. Epidemiol Rev. 2007;29:77-87
13. Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity: A magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut. 2005;54:122-127
14. Eguchi Y, Eguchi T, Mizuta T, et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol. 2006;41:462-469
15. van der Poorten D, Milner KL, Hui J, et al. Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48:449-457
16. Yim JY, Kim D, Lim SH, et al. Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care. 2010;33:2665-2670
17. Kwak MS, Kim D, Chung GE, et al. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. Liver Int. 2015;35:944-952
18. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847
19. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419
20. Lee JK, Shim JH, Lee HC, et al. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology. 2010;51:1577-1583
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497
22. Chung SJ, Kim D, Park MJ, et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: A cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut. 2008;57:1360-1365
23. Kim D, Choi SY, Park EH, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012;56:605-613
24. Choi SY, Kim D, Kim HJ, et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol. 2009;104:1953-1960
25. Park HS, Han JH, Choi KM, et al. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005;82:1046-1051
26. Oh SY, Cho YK, Kang MS, et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism. 2006;55:1604-1609
27. Vozarova B, Stefan N, Lindsay RS, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51:1889-1895
28. Hanley AJ, Wagenknecht LE, Festa A, et al. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: The Insulin Resistance Atherosclerosis Study. Diabetes Care. 2007;30:1819-1827
29. Degrace P, Demizieux L, Du ZY, et al. Regulation of lipid flux between liver and adipose tissue during transient hepatic steatosis in carnitine-depleted rats. J Biol Chem. 2007;282:20816-20826
30. Czaja MJ. Liver injury in the setting of steatosis: crosstalk between adipokine and cytokine. Hepatology. 2004;40:19-22
31. Kern PA, Ranganathan S, Li C, et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280:E745-E751
32. Hui JM, Hodge A, Farrell GC, et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology. 2004;40:46-54
33. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705-1725
34. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745-750
35. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592-1609